Company / Book Value per Share
Edgewise Therapeutics, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.074
FY2025
5-year range
$4.969 / $7.312
FY2021-FY2025
Trend
+2.1%
vs FY2024
Sector context
#105 of 209
Health Care
What the data says
At $5.074, Edgewise Therapeutics, Inc.'s book value per share ranks #105 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $5.074.
Based on SEC 10-K filings.
$5.074 in FY2025 with a 3-year CAGR of -7.8%.
Remained stable around $5.074 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 209 in Health CareTop 50% of 209This company $5.074 Sector average $215.686
▼
-97.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -7.8%, indicating a declining trend.
- In FY2025, book value per share increased 2.1% year-over-year.
- Ranks #105 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.074 | +2.1% |
| FY2024 | $4.969 | -0.7% |
| FY2023 | $5.003 | -22.7% |
| FY2022 | $6.469 | -11.5% |
| FY2021 | $7.312 | +116.2% |
| FY2020 | -$45.223 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026